PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AGN.AX vs. VOO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between AGN.AX and VOO is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

AGN.AX vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Argenica Therapeutics Limited (AGN.AX) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-31.69%
3.78%
AGN.AX
VOO

Key characteristics

Sharpe Ratio

AGN.AX:

0.13

VOO:

1.88

Sortino Ratio

AGN.AX:

0.68

VOO:

2.52

Omega Ratio

AGN.AX:

1.08

VOO:

1.35

Calmar Ratio

AGN.AX:

0.17

VOO:

2.83

Martin Ratio

AGN.AX:

0.50

VOO:

11.96

Ulcer Index

AGN.AX:

16.75%

VOO:

2.00%

Daily Std Dev

AGN.AX:

66.51%

VOO:

12.70%

Max Drawdown

AGN.AX:

-69.19%

VOO:

-33.99%

Current Drawdown

AGN.AX:

-34.34%

VOO:

-3.91%

Returns By Period

In the year-to-date period, AGN.AX achieves a 3.17% return, which is significantly higher than VOO's -0.66% return.


AGN.AX

YTD

3.17%

1M

-5.11%

6M

-25.71%

1Y

8.33%

5Y*

N/A

10Y*

N/A

VOO

YTD

-0.66%

1M

-3.35%

6M

3.78%

1Y

23.82%

5Y*

13.79%

10Y*

13.26%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AGN.AX vs. VOO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AGN.AX
The Risk-Adjusted Performance Rank of AGN.AX is 5555
Overall Rank
The Sharpe Ratio Rank of AGN.AX is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of AGN.AX is 5454
Sortino Ratio Rank
The Omega Ratio Rank of AGN.AX is 5252
Omega Ratio Rank
The Calmar Ratio Rank of AGN.AX is 5858
Calmar Ratio Rank
The Martin Ratio Rank of AGN.AX is 5656
Martin Ratio Rank

VOO
The Risk-Adjusted Performance Rank of VOO is 8282
Overall Rank
The Sharpe Ratio Rank of VOO is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of VOO is 8080
Sortino Ratio Rank
The Omega Ratio Rank of VOO is 8282
Omega Ratio Rank
The Calmar Ratio Rank of VOO is 8282
Calmar Ratio Rank
The Martin Ratio Rank of VOO is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AGN.AX vs. VOO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Argenica Therapeutics Limited (AGN.AX) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AGN.AX, currently valued at -0.04, compared to the broader market-2.000.002.00-0.041.72
The chart of Sortino ratio for AGN.AX, currently valued at 0.42, compared to the broader market-4.00-2.000.002.004.000.422.31
The chart of Omega ratio for AGN.AX, currently valued at 1.05, compared to the broader market0.501.001.502.001.051.32
The chart of Calmar ratio for AGN.AX, currently valued at -0.05, compared to the broader market0.002.004.006.00-0.052.56
The chart of Martin ratio for AGN.AX, currently valued at -0.15, compared to the broader market0.0010.0020.00-0.1510.70
AGN.AX
VOO

The current AGN.AX Sharpe Ratio is 0.13, which is lower than the VOO Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of AGN.AX and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.04
1.72
AGN.AX
VOO

Dividends

AGN.AX vs. VOO - Dividend Comparison

AGN.AX has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.25%.


TTM20242023202220212020201920182017201620152014
AGN.AX
Argenica Therapeutics Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.25%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%1.85%

Drawdowns

AGN.AX vs. VOO - Drawdown Comparison

The maximum AGN.AX drawdown since its inception was -69.19%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for AGN.AX and VOO. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-43.62%
-3.91%
AGN.AX
VOO

Volatility

AGN.AX vs. VOO - Volatility Comparison

Argenica Therapeutics Limited (AGN.AX) has a higher volatility of 11.27% compared to Vanguard S&P 500 ETF (VOO) at 4.55%. This indicates that AGN.AX's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
11.27%
4.55%
AGN.AX
VOO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab